Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report

Psychological Medicine

Volumn 42, Issue 6, 2012, Pages 1131-1149

  Rush, A J ^a   Wisniewski, S R ^b   Zisook, S ^c   Fava, M ^d   Sung, S C ^a   Haley, C L ^a   Chan, H N ^e   Gilmer, W S ^f   Warden, D ^g   Nierenberg, A A ^d   Balasubramani, G K ^b   Gaynes, B N ^h   Trivedi, M H ^f   Hollon, S D ⁱ  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

Author keywords

Chronic; Course of illness; Depression; Outcomes; Recurrent

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR DEPRESSION; MALE; MIDDLE AGED; OUTPATIENT; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; CITALOPRAM; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84860758903     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711002170     Document Type: Article

References (53)

1. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 22, 343-396. (Pubitemid 351989984)
2. Angst J, Gamma A, Ro? ssler W, Ajdacic V, Klein DN (2009). Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. Journal of Affective Disorders 115, 112-121.
3. APA (2000a). Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. American Journal of Psychiatry 157 (Suppl. 4), 1-45.
4. APA (2000b). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.
5. Bernstein IH, Rush AJ, Carmody TJ, Woo A, Trivedi MH (2007). Clinical vs. self-report versions of the Quick Inventory of Depressive Symptomatology in a public sector sample. Journal of Psychiatric Research 41, 239-246. (Pubitemid 44854989)
6. Blanco C, Okuda M, Markowitz JC, Liu SM, Grant BF, Hasin DS (2010). The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 71, 1645-1656.
7. Bockting CL, Spinhoven P, Wouters LF, Koeter MW, Schene AH; DELTA Study Group (2009). Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study. Journal of Clinical Psychiatry 70, 1621-1628.
8. Carmody TJ, Rush AJ, Bernstein IH, Brannan S, Husain MM, Trivedi MH (2006). Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS. Journal of Affective Disorders 95, 115-118. (Pubitemid 46107018)
9. Conradi HJ, de Jonge P, Ormel J (2008). Cognitivebehavioural therapy v. usual care in recurrent depression. British Journal of Psychiatry 193, 505-506.
10. Depression Guideline Panel (1993). Clinical Practice Guideline, Number 5: Depression in Primary Care: Volume 2. Treatment of Major Depression. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research: Rockville, MD.
11. Fava GA, Ruino C, Rafanelli C, Finos L, Conti S, Grandi S (2004a). Six-year outcome of cognitive behaviour therapy for prevention of recurrent depression. American Journal of Psychiatry 161, 1872-1876. (Pubitemid 39314682)
12. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ (2004b). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine 34, 1299-1308. (Pubitemid 39517160)
13. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ (2003). Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatric Clinics of North America 26, 457-494, x. (Pubitemid 36583573)
14. Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, Yohanna D, Khan A, Alpert J (2005). Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatrica Scandinavica 112, 425-433. (Pubitemid 41676686)
15. Guidi J, Fava GA, Fava M, Papakostas GI (2011). Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychological Medicine 41, 321-331.
16. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56-62.
17. Hamilton M (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
18. Hollon SD, Shelton RC, Wisniewski S, Warden D, Biggs MM, Friedman ES, Husain M, Kupfer DJ, Nierenberg AA, Petersen TJ, Shores-Wilson K, Rush AJ (2006). Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. Journal of Psychiatric Research 40, 59-69. (Pubitemid 43117528)
19. Jonsson U, Bohman H, von Knorring L, Olsson G, Paaren A, von Knorring AL (2011). Mental health outcome of long-term and episodic adolescent depression: 15-year follow-up of a community sample. Journal of Affective Disorders 130, 395-404.
20. Kanai T, Takeuchi H, Furukawa TA, Yoshimura R, Imaizumi T, Kitamura T, Takahashi K (2003). Time to recurrence after recovery from major depressive episodes and its predictors. Psychological Medicine 33, 839-845. (Pubitemid 36874663)
21. Kaymaz N, van Os J, Loonen AJ, NolenWA(2008). Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. Journal of Clinical Psychiatry 69, 1423-1436.
22. Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, Rush AJ, Stegman D, Kelley C, Kreiner K, Nierenberg AA, Fava M (2006). Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry 18, 91-98. (Pubitemid 43879896)
23. Klein DN (2008). Classification of depressive disorders in the DSM-V: proposal for a two-dimension system. Journal of Abnormal Psychology 117, 552-560.
24. Klein DN (2010). Chronic depression: diagnosis and classification. Current Directions in Psychological Science 19, 96-100.
25. Kocsis JH, Rush AJ, Markowitz JC, Borian FE, Dunner DL, Koran LM, Klein DN, Trivedi MH, Arnow B, Keitner G, Kornstein SG, Keller MB (2003). Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacology Bulletin 37, 73-87.
26. Kriston L, von Wolff A, Ho?lzel L (2010). Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON). BMC Psychiatry 10, 95.
27. Linn BS, Linn MW, Gurel L (1968). Cumulative illness rating scale. Journal of the American Geriatrics Society 16, 622-626.
28. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds 3rd CF (1992). Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Research 41, 237-248.
29. Mondimore FM, Zandi PP, Mackinnon DF, McInnis MG, Miller EB, Crowe RP, Scheftner WA, Marta DH, Weissman MM, Levinson DF, Murphy-Ebenez KP, Depaulo Jr. JR, Potash JB (2006). Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees. American Journal of Psychiatry 163, 1554-1560. (Pubitemid 44465755)
30. Nierenberg AA, Trivedi MH, Ritz L, Burroughs D, Greist J, Sackeim H, Kornstein S, Schwartz T, Stegman D, Fava M, Wisniewski SR (2004). Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines. Journal of Psychiatric Research 38, 583-589. (Pubitemid 39348890)
31. Novick JS, Stewart JW,Wisniewski SR, Cook IA, Manev R, Nierenberg AA, Rosenbaum JF, Shores-Wilson K, Balasubramani GK, Biggs MM, Zisook S, Rush AJ (2005). Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. Journal of Clinical Psychiatry 66, 1002-1011. Nutt DJ (2010). (Pubitemid 41191792)
32. Rationale for, barriers to, and appropriate medication for the long-term treatment of depression. Journal of Clinical Psychiatry 71 (Suppl. E1), e02.
33. Pettit JW, Lewinsohn PM, Roberts RE, Seeley JR, Monteith L (2009). The long-term course of depression: development of an empirical index and identification of early adult outcomes. Psychological Medicine 39, 403-412.
34. Roca M, Armengol S, Garca-Garca M, Rodriguez-Bayo?n A, Ballesta I, Serrano MJ, Comas A, GiliM(2011). Clinical differences between first and recurrent episodes in depressive patients. Comprehensive Psychiatry 52, 26-32.
35. Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M (2006a). An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biological Psychiatry 59, 493-501. (Pubitemid 43320536)
36. Rush AJ, Carmody TJ, Ibrahim HM, Trivedi MH, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM (2006b). Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatric Services 57, 829-837. (Pubitemid 43846295)
37. Rush AJ, Carmody TJ, Reimitz PE (2000). The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research 9, 45-59.
38. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G (2004). Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Controlled Clinical Trials 25, 119-142.
39. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 26, 477-486. (Pubitemid 26142491)
40. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF (2006c). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1842-1853.
41. Rush AJ, Trivedi MH, Carmody TJ, Ibrahim H, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB (2005a). Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology 30, 405-416. (Pubitemid 40129492)
42. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573-583. (Pubitemid 37289444)
43. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther JF, Thomas B, Trivedi MH (2005b). Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. Journal of Affective Disorders 87, 43-55. (Pubitemid 40828202)
44. Satyanarayana S, Enns MW, Cox BJ, Sareen J (2009). Prevalence and correlates of chronic depression in the Canadian community health survey: mental health and well-being. Canadian Journal of Psychiatry 54, 389-398.
45. Solomon DA, Keller MB, Leon AC, Mueller TI, Shea MT, Warshaw M, Maser JD, Coryell W, Endicott J (1997). Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Archives of General Psychiatry 54, 1001-1006.
46. Stegenga BT, Kamphuis MH, King M, Nazareth I, Geerlings MI (2010). The natural course and outcome of major depressive disorder in primary care: the PREDICT-NL study. Social Psychiatry and Psychiatric Epidemiology. Published online: 6 November 2010. doi:10.1007/s00127-010-0317-9.
47. Trivedi MH, Rush AJ, Gaynes BN, Stewart JW, Wisniewski SR, Warden D, Ritz L, Luther JF, Stegman D, DeVeaugh-Geiss J, Howland R (2007). Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology 32, 2479-2489. (Pubitemid 350126843)
48. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 34, 73-82. (Pubitemid 38139442)
49. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 28-40.
50. Vuorilehto MS, Melartin TK, Isometsa? ET (2009). Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychological Medicine 39, 1697-1707.
51. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA, for the STAR*D Investigators (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 12, 71-79. (Pubitemid 44284089)
52. Zimmerman M, Mattia JI (2001a). A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry 58, 787-794. (Pubitemid 32717805)
53. Zimmerman M, Mattia JI (2001b). The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Comprehensive Psychiatry 42, 175-189. (Pubitemid 32410920)